Wilmot Cancer Expert Offers Overview on Myeloma Care Oct. 28
October 15, 2008
Treatment options for myeloma, a rare blood cancer, will be discussed at 6 p.m. Tuesday, Oct. 28, at Gilda’s Club. The free program is sponsored by the Leukemia & Lymphoma Society.
Gordon L. Phillips, M.D., director of the James P. Wilmot Cancer Center’s Samuel E. Durand Blood and Marrow Transplant Program, will lead the discussion of milestones in myeloma therapy. He will provide an overview of treatment options, clinical trials, symptom management and how to communicate with their healthcare provider.
Myeloma is a cancer of plasma in the blood and is diagnosed in about 19,920 people in the United States each year.
To register for the program, which includes a dinner beginning at 5 p.m., call The Leukemia & Lymphoma Society at 1-800-784-2368 ext. 106.